News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 863
- Sources here
- 22
- Companies here
- 12
Active search
863 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Gossamer Bio: Q2 Earnings Snapshot
This article provides a Q2 earnings snapshot for Gossamer Bio. Due to the limited content, specific financial details or performance indicators are not available.
Fossil Group: Q2 Earnings Snapshot
Fossil Group Inc. (FOSL) reported a second-quarter loss of $10.6 million. The Richardson, Texas-based watch and accessories maker posted a loss of 18 cents per share, or 13 cents per share when adjusted for one-time gains and costs. The company's revenue for the period …
Ross Stores shares may swing 6.5% on Aug. 20 earnings report
Ross Stores Inc. (NASDAQ:ROST) shares are predicted to move by 6.5% following its earnings report on August 20, according to options data. Historically, the stock's actual price movement has exceeded the implied move from options traders in six out of the last eight earnings …
Q2 2026 Fossil Group Inc Earnings Call Transcript
Fossil Group Inc. (FOSL) reported strong Q2 2026 results, exceeding expectations with net sales of $211 million and a significant gross margin expansion to 62.4%. Despite a 4% decline in net sales year-over-year, the company doubled its adjusted operating income and raised its full-year …
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
Gossamer Bio announced its Q2 2026 financial results and provided a business update, highlighting its progress toward an NDA submission for seralutinib in PAH by September 2026. The company reacquired worldwide development and commercial rights for seralutinib and significantly reduced its debt through a …
Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm
Kuehn Law is investigating whether officers and directors of Gossamer Bio, Inc. (NASDAQ: GOSS) breached their fiduciary duties to shareholders regarding misrepresentations about its Phase 3 PROSERA study for pulmonary arterial hypertension (PAH). The lawsuit alleges the company failed to disclose material issues with …
Fossil Group, Inc. 2026: Revenue $209.69M, EPS ($0.18) — 10-Q Summary
Fossil Group, Inc. reported Q3 2026 results with revenue of $209.69 million and a diluted loss per share of ($0.18), indicating a decline in revenue by 4.9% year-over-year. The company faced challenges from softer demand in Europe and weakness in direct-to-consumer channels, though gross …
Cross Timbers Royalty Trust (NYSE:CRT) Major Shareholder Eric Oliver Buys 12,950 Shares
Cross Timbers Royalty Trust (NYSE:CRT) major shareholder Eric Oliver recently bought 12,950 shares at $10.08, increasing his stake to over 951,000 shares. The trust's shares rose by 0.7% to $10.18, and it reported quarterly earnings of $0.14 per share while increasing its monthly dividend …
Ross Stores (NasdaqGS:ROST) Stock Price
This article provides an overview of Ross Stores (NasdaqGS:ROST) stock performance, fair value estimations from various analysts, and key financial details. It highlights different perspectives on the company's valuation, considering factors like its cash-rich balance sheet, aggressive store expansion, and the impact of retail …
Gossamer Bio (GOSS) Reports Q2 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …
Ross Stores (ROST) Stock Looks Rich On Earnings But Strong On Returns
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Ross Stores stock has delivered a strong run over the last few years, yet …
Gossamer Bio, Inc. 2026: Revenue $9.24M, Net income $16.9M, EPS ($0.08) — 10-Q Summary
Gossamer Bio, Inc. reported its current quarter 2026 financial results, showing revenue of $9.24 million and a net income of $16.9 million, a significant improvement from a net loss in the prior year. The company also highlighted positive Phase 3 clinical trial results for …
Cross Timbers Royalty Trust (NYSE:CRT) Posts Earnings Results
Cross Timbers Royalty Trust (NYSE:CRT) reported earnings per share of $0.14 for the quarter, with a strong return on equity of 145.81% and a net margin of 71.40%. The trust increased its monthly dividend to $0.0614 per share, translating to an annualized yield of …
Fossil Group (NASDAQ: FOSL) posts deeper Q2 2026 loss amid rising interest costs
Fossil Group reported a wider net loss of $10.6 million in Q2 2026, compared to $2.3 million a year earlier, primarily due to significantly increased interest costs that more than doubled to $8.3 million. Sales declined by 4.9% to $209.7 million, impacted by store …
Fossil Group, Inc. Reports Second Quarter 2026 Financial Results
Fossil Group, Inc. reported second-quarter 2026 financial results exceeding expectations, driven by strong performance across brands and geographies. The company saw net sales of $209.7 million, a gross margin increase to 62.4%, and raised its full-year 2026 financial outlook, anticipating a return to top-line …
CROSS TIMBERS ROYALTY TRUST Q2 2026: Revenue $3.55M, Net income $1.09M — 10-Q Summary
CROSS TIMBERS ROYALTY TRUST (CRT) reported its Q2 2026 results with revenue of $3.55M and net income of $1.09M, representing declines of 1% and 16% respectively compared to the previous year. These declines were attributed to lower gas prices, reduced production volumes, and higher …
Cross Timbers Royalty Trust (CRT) net profits income falls 44% in first half 2026
Cross Timbers Royalty Trust (CRT) reported a 44% decrease in net profits income for the first half of 2026, falling to $1.86 million, and a 16% decrease for Q2 2026 compared to the previous year. This decline was primarily due to lower oil and …
Here's How Ross Stores Stock is Poised Ahead of Q2 Earnings
Ross Stores, Inc. ROST is likely to post year-over-year top and bottom-line growth when it reports second-quarter fiscal 2026 earnings on Aug. 20, after market close. The Zacks Consensus Estimate for quarterly revenues is pegged at $6.1 billion, indicating a rise of 10.7% from …
Sharemaestro market context Trend signal active 52 weeks +98.1%Ross Stores Inc. stock underperforms Thursday when compared to competitors
Shares of Ross Stores Inc. (ROST) fell 1.33% on Thursday, closing at $244.96. This underperformance occurred on an otherwise positive day for the broader market, with both the S&P 500 and Dow Jones Industrial Average posting gains. This marked the fourth consecutive day of …
Gossamer Bio Inc (GOSS) News, Articles, Events & Latest Updates
Gossamer Bio Inc (GOSS) recently reported its Q2 2026 financial results, showing a loss but exceeding revenue estimates. The company, a clinical-stage biopharmaceutical firm, is focusing on developing seralutinib for pulmonary arterial hypertension. Several legal firms are investigating the company, and its stock has …
Ross Stores, Inc. (0KXO.L) Analyst insights, Price targets and Recommendations
This article provides analyst insights, price targets, and recommendations for Ross Stores, Inc. (0KXO.L). It lists several recent analyst upgrades and downgrades from firms like Wells Fargo, Barclays, Telsey Advisory Group, Truist Securities, and UBS, along with their respective dates. The stock's current trading …
Ross Stores (ROST) Earnings Expected to Grow: Should You Buy?
Ross Stores (ROST) is projected to report a year-over-year increase in earnings and revenues for the quarter ended July 2026, with an expected release on August 20. The company's Zacks Earnings ESP of +4.03% and a Zacks Rank #3 suggest a high probability of …
Sharemaestro market context Trend signal active 52 weeks +98.1%